CALGB 80403 (Alliance)/E1206: A Randomized Phase II Study of Three Chemotherapy Regimens Plus Cetuximab in Metastatic Esophageal and Gastroesophageal Junction Cancers. [electronic resource]
Producer: 20170726Description: 2736-42 p. digitalISSN:- 1527-7755
- Adenocarcinoma -- drug therapy
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- adverse effects
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Camptothecin -- administration & dosage
- Carcinoma, Squamous Cell -- drug therapy
- Cetuximab -- administration & dosage
- Cisplatin -- administration & dosage
- Disease Progression
- Disease-Free Survival
- Epirubicin -- administration & dosage
- Esophageal Neoplasms -- drug therapy
- Esophagogastric Junction
- Female
- Fluorouracil -- administration & dosage
- Humans
- Irinotecan
- Leucovorin -- administration & dosage
- Male
- Middle Aged
- Organoplatinum Compounds -- administration & dosage
- Survival Rate
- Time Factors
- Treatment Failure
No physical items for this record
Publication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.